Forty Seven, Inc. | Next Generation Immuno-Oncology
Meta Description
Forty Seven, Inc. is committed to the advancement of immuno-oncology through the engagement of new and complementary phagocytic pathways that enhance anti-tumor efficacy and selectivity.
Meta Keywords
Technologies in use
concrete5, Google Analytics, jQuery, Angular, Bootstrap, Font Awesome